Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Univariate analyses for overall survival in metastatic gastric cancer patients (n = 123)

From: Identification of prognostic factors and surgical indications for metastatic gastric cancer

Variable Median survival (months) p value
Age (years)   0.362
  >65 13.4  
  < 65 13.1  
Sex   0.583
  Female 11.1  
  Male 14.2  
PS   < 0.001
  0, 1, 2 14.2  
  3 2.4  
Body mass index (kg/m2)   0.242
  < 21 11.1  
  >21 14.9  
Hb (g/dL)   0.428
  < 12 13.4  
  >12 13.1  
NLR   < 0.001
  < 3.1 16.5  
  >3.1 8.2  
CRP (mg/dL)   0.005
  < 0.2 15.4  
  >0.2 9.8  
Alb (g/dL)   < 0.001
  < 3.5 6.7  
  >3.5 15.6  
CEA (ng/mL)   0.052
  < 6 14.2  
  >6 9.7  
CA19-9 (U/mL)   0.003
  < 37 15.3  
  >37 9.7  
Tumor location in stomach   0.267
  Upper 13.4  
  Middle 12.3  
  Lower 14.2  
  Whole 7.4  
Histological differentiation   0.829
  Differentiated 14.6  
  Undifferentiated 11.4  
Adjacent organ invasion   0.009
  Yes 7.8  
  No 14.6  
Bulky lymph nodes   0.011
  Yes 9.3  
  No 12.5  
Metastasis to organs   0.044
  1 organ 15.4  
  ≥2 organs 10.1  
Peritoneal metastasis   0.174
  Present 11.1  
  Absent 16.2  
Hepatic metastasis   0.556
  Present 15.3  
  Absent 11.4  
Distant lymph node metastasis   0.117
  Present 10.1  
  Absent 14.6  
Gastrectomy   < 0.0001
  Present 15.6  
  Absent 7.2  
Chemotherapy   0.007
  Yes 14.4  
  No 4.7